{"nct_id":"NCT03276962","title":"Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age","status":"COMPLETED","status_verified_date":"2024-05","start_date":"2017-09-28","start_date_type":"ACTUAL","primary_completion_date":"2019-11-04","primary_completion_date_type":"ACTUAL","completion_date":"2022-11-14","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}